Mother Jones recently published a piece with text by Julie Winokur and photos by Ed Kashi about immigrant detention in the United States.
Julie writes, “When asylum seekers arrive in the United States they face a harsh reality. The ones who aren’t illegally turned away at the border are often sequestered, shackled, and transported to a detention facility that resembles prison.”
See the photos
Out today in Bloomberg Businessweek is Nichole Sobecki’s cover story “Made in Ethiopia, by China.”
Fast fashion finds a new home in the Horn of Africa, where tax incentives, promises of infrastructure development, and ultra-cheap labor are drawing in companies producing for Guess, Levi’s, H&M and other labels. The Hawassa Industrial Park is only the most recent part of a vast centralized scheme: since 2014, Ethiopia has opened four giant, publicly owned industrial parks; it plans eight more by 2020.
See the story
Featured today on The New Yorker is a story that Zackary Canepari photographed while embedded with the police in Flint, Michigan.
“The photographer Zackary Canepari is among the few outsiders with sustained interest in the internal rot of this American city. A native of Boston who now lives between New York and the Bay Area, he has been documenting life in Flint since 2012, including the water crisis that poisoned the city’s residents; an eight-part documentary series called “Flint Town,” which Canepari made with Jessica Dimmock and Drea Cooper, premières on March 2nd, on Netflix. For his most recent series of images, he examined the Flint Police Department. How does law enforcement work in a place in constant crisis?”
See the story
In Ed Kashi’s photo from August 2017, Laurel Cline visits her mother Lenora in a nursing home in Los Angeles, California. This morning, AP announced a new report detailing misuse of antipsychotics in nursing homes. Analyzing the latest government data, Human Rights Watch estimates that there are currently about 179,000 people in nursing homes who get antipsychotics every week without having a diagnosis for which the drugs are approved.
See more publications of this report: